Hidden Patterns in Medical Records Reveal the Genetic Roots of Preterm Birth

Preterm birth, the delivery of a baby before thirty-seven weeks of gestation, remains one of the most stubborn puzzles in modern medicine. It is the leading cause of death in newborns worldwide, and children who survive often face lifelong complications ranging from respiratory illness to neurodevelopmental disorders. Yet despite decades of research, clinicians still cannot reliably predict which pregnancies will end early, and the biological mechanisms driving preterm delivery have remained frustratingly opaque. A new study published in BMC Medicine suggests that a major reason for this blind spot may be the way we define the condition itself. Rather than a single disease, the researchers argue, preterm birth is a bundle of distinct syndromes, each with its own clinical fingerprint and its own genetic underpinnings, hiding in plain sight inside millions of routine medical records.

The research team, led by Abin Abraham of Children’s Hospital of Philadelphia together with collaborators at the University of California, San Francisco, Vanderbilt University Medical Center, and Vanderbilt University, took an unconventional approach to the problem. Instead of treating preterm birth as a yes-or-no label, they mined longitudinal electronic health records from nearly sixty thousand individuals across two separate clinical sites. Their goal was to let the data reveal natural groupings of conditions that tend to co-occur in the weeks and months surrounding delivery, and to test whether those groupings, once uncovered, could connect the clinical presentation of preterm birth to its inherited risk. The work was supported in part by the March of Dimes and the National Institutes of Health, reflecting a growing recognition that solving preterm birth requires both computational scale and genetic depth.

The mathematical engine behind the study is called tensor decomposition, a technique that will be familiar to physicists and data scientists but has only recently found traction in medicine. A tensor is simply a multi-dimensional array, and in this case the array captured three dimensions at once: patients, comorbid diagnoses, and the timing of those diagnoses relative to delivery. The researchers applied a classical decomposition method known as CANDECOMP/PARAFAC, which breaks a large, unwieldy tensor into a small set of latent factors. Each latent factor is essentially a pattern, a coherent combination of conditions and a temporal trajectory that recurs across many patients. Where a human clinician might see a chaotic list of diagnoses, the algorithm sees recurring themes, such as a cluster of metabolic conditions that spike at a particular window before birth.

What emerged from the decomposition was striking. The analysis uncovered latent factors corresponding to recognizable clinical territories, including metabolic disease, inflammatory conditions, and mental health disorders, each with its own characteristic timing relative to delivery. Some factors were enriched in preterm births while others tracked with term deliveries, suggesting that the patterns are not generic artifacts of pregnancy but genuinely differentiating signatures. Crucially, the team ran the same analysis independently at both clinical sites and found that similar factors surfaced at each one. This replication across institutions is a critical sanity check in computational phenotyping, because it demonstrates that the discovered patterns reflect real biology and shared clinical structure rather than the idiosyncrasies of a single hospital’s coding practices or patient population.

The latent factors were not merely descriptive curiosities. When the researchers trained machine learning models to predict preterm birth, models built on the compressed latent factor representation performed comparably to models trained on the full, high-dimensional electronic health record data. That result carries practical weight: a handful of interpretable factors can substitute for thousands of raw diagnostic codes without sacrificing predictive accuracy. In other words, the decomposition achieved a rare double win in medical machine learning, compressing the data while making it more transparent. Clinicians and regulators are often wary of black-box models, and a predictor built from factors with clear clinical meanings, such as a hypertensive disorder trajectory, is far easier to scrutinize, validate, and ultimately deploy at the bedside than an opaque ensemble of raw codes.

The study’s most ambitious move was to connect these clinical patterns to genetics. Twin studies have long indicated that preterm birth has a substantial heritable component, but genome-wide association studies have struggled to pin down specific mechanisms, partly because the phenotype itself is so heterogeneous. The team integrated genome-wide genotyping data for more than 2,200 individuals in the cohort and calculated polygenic risk scores, which aggregate the small effects of thousands of genetic variants across the genome into a single number for each trait. When they tested whether genetic predisposition to other conditions influenced preterm birth risk, a clear signal appeared: women carrying a high polygenic burden for cardiometabolic traits, including cardiovascular disease, type 2 diabetes, and elevated body mass index, faced robustly elevated odds of delivering preterm.

That association raised an obvious question: how does genetic risk for heart disease and diabetes translate into an early delivery? To answer it, the researchers turned to mediation analysis, a statistical framework for testing whether an observed relationship between two variables travels through an intermediate one. Here the intermediates were the latent factors themselves. The results were compelling. A latent factor capturing hypertensive disorders of pregnancy, such as preeclampsia, transmitted part of the cardiometabolic polygenic risk to preterm birth. In plain terms, inherited susceptibility to metabolic and cardiovascular disease appears to raise preterm birth risk partly by manifesting as hypertension during pregnancy, which in turn drives early delivery. This provides a mechanistic bridge linking a woman’s genome, her pregnancy complications, and her delivery outcome, and it reframes preterm birth as one downstream consequence of a broader cardiometabolic diathesis.

The implications of this framing extend beyond academic taxonomy. If preterm birth is not one disease but several, then prevention strategies may need to be tailored to sub-phenotype. A pregnancy marked by a metabolic-inflammatory trajectory might warrant intensified glucose monitoring and early blood pressure management, while a trajectory dominated by mental health conditions could call for entirely different surveillance and support. The latent factor framework also offers a principled way to stratify patients in future genetic studies, potentially boosting statistical power by analyzing genetically coherent subgroups rather than a blended population. And because the factors are computable from data that hospitals already collect, the approach could in principle be retrofitted onto existing records systems without new tests or expensive instrumentation, lowering the barrier to clinical translation.

There are, of course, important caveats. Electronic health records are notoriously noisy, shaped by inconsistent diagnostic coding, variable access to care, and the biases of who gets recorded and why. The genetic subsample of the cohort, at just over 2,200 individuals with genotyping, is modest by the standards of modern genomics, and the mediation findings, while robust within this dataset, will need replication in larger and more ancestrally diverse cohorts before they can guide practice. The authors themselves note that the study is a step toward refining the preterm birth phenotype, not a finished clinical tool. Still, the convergence of evidence, from replicated latent factors across two sites to predictive parity with full-record models to genetically mediated risk pathways, makes a persuasive case that the approach captures something real.

The broader lesson may resonate far beyond obstetrics. Preterm birth is hardly the only complex condition whose definition lumps together biologically distinct entities; depression, chronic kidney disease, and many autoimmune disorders suffer from the same problem, and the same genetic heterogeneity that has stalled their own genome-wide studies. This study offers a template: use tensor decomposition on longitudinal records to discover latent phenotypes, verify them across institutions, and then interrogate them with polygenic risk scores and mediation analysis to expose the pathways connecting genes to outcomes. If that pipeline generalizes, the humble medical record, long viewed as a billing byproduct, may become one of the most powerful instruments in precision medicine. For the roughly one in ten infants born preterm each year, and for the mothers whose pregnancies follow hidden trajectories that medicine is only now learning to read, that possibility is more than an abstraction. It is a roadmap toward prediction, prevention, and, ultimately, longer and healthier lives that begin at term.

Subject of Research: Latent phenotyping of preterm birth using tensor decomposition of electronic health records and its links to polygenic genetic risk

Article Title: Discovering latent phenotypic signatures of preterm birth and genetic risk using tensor decomposition on electronic health records

Article References: Abraham, A., Takasuka, H., Bejan, C., Rinker, D., Rokas, A., Sirota, M., & Capra, J. A. (2026). Discovering latent phenotypic signatures of preterm birth and genetic risk using tensor decomposition on electronic health records. BMC Medicine. https://doi.org/10.1186/s12916-026-05203-1

Image Credits: AI Generated

DOI: 10.1186/s12916-026-05203-1

Keywords: preterm birth, electronic health records, tensor decomposition, latent factors, polygenic risk score, computational phenotyping, machine learning, hypertensive disorders of pregnancy, cardiometabolic traits, genetic association study, comorbidity trajectories, BMC Medicine